NGM Biopharmaceuticals
Patents, Design & Utilities

Last updated:

List of all NGM Biopharmaceuticals patents 62 in total

Status Patent
Application
Utility: Methods and Compositions for the Treatment of Metabolic Disorders and Diseases External link
Filling date: 7 Sep 2025 Issue date: 20 Feb 2020
Grant
Utility: Compositions and methods of use for treating metabolic disorders External link
Filling date: 7 Sep 2025 Issue date: 18 Feb 2020
Application
Utility: COMBINATION THERAPY WITH GLUCAGON RECEPTOR ANTAGONISTS External link
Filling date: 7 Sep 2025 Issue date: 13 Feb 2020
Grant
Utility: Pharmaceutical compositions comprising FGF19 variants External link
Filling date: 7 Sep 2025 Issue date: 31 Dec 2019
Application
Utility: BINDING PROTEINS AND METHODS OF USE THEREOF External link
Filling date: 7 Sep 2025 Issue date: 7 Nov 2019
Grant
Utility: Methods and uses for modulating bile acid homeostasis and treatment of bile acid disorders and diseases External link
Filling date: 7 Sep 2025 Issue date: 29 Oct 2019
Application
Utility: C3-BINDING AGENTS AND METHODS OF USE THEREOF External link
Filling date: 7 Sep 2025 Issue date: 24 Oct 2019
Application
Utility: METHODS FOR TREATMENT OF BILE ACID-RELATED DISORDERS External link
Filling date: 7 Sep 2025 Issue date: 10 Oct 2019
Grant
Utility: Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disorders External link
Filling date: 7 Sep 2025 Issue date: 8 Oct 2019
Grant
Utility: Methods of using compositions comprising variants of FGF19 polypeptides for reducing body mass in a subject External link
Filling date: 7 Sep 2025 Issue date: 17 Sep 2019
Grant
Utility: Compositions comprising variants of FGF19 polypeptides and uses thereof for the treatment of hyperglycemic conditions External link
Filling date: 7 Sep 2025 Issue date: 3 Sep 2019
Grant
Utility: Methods of using variants of FGF19 polypeptides for the treatment of cancer External link
Filling date: 7 Sep 2025 Issue date: 6 Aug 2019

Showing 50 to 62 of 62 patents.